Peter D. Suzdak, Ph.D. is a innovative and results orientated pharmaceutical executive with more than 35 years experience with U.S. and European based pharmaceutical companies. Dr. Suzdak has a established track record of in business development, drug discovery, preclinical development and clinical development. Dr. Suzdak has previously co-founded multiple pharma companies including Artesian Therapeutics (which was acquired by Cardiome Pharma), Cardioxyl Pharmaceuticals (which was acquired by Bristol-Myers Squibb), Corridor Pharmaceuticals and Sonoval Therapeutics. Dr. Suzdak has been involved in filing 17 IND’s and 3 NDA/sNDA’s.
